BURBANK, Calif., May 15, 2006 (PRIMEZONE) -- Imaging3, Inc, (OTCBB:IMGG), developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, today announces that the company has retained the services of SyProSoft Engineering. SyProSoft's award winning team of developmental software engineers will accelerate the development cycle of Imaging3's radical new medical imaging device, the Dominion.
SyProSoft Engineering, based in Irvine, California, offers a full range of R&D services, including software, electrical and mechanical engineering. "We have strong expertise and extensive experience in the development of medical devices especially in cardiovascular, surgical, diagnostic, radiological and oncology equipment," stated Dipu Ghosh, President of SyProSoft Engineering. For more information, please visit www.syprosoft.com.
"We are pleased to retain the services of SyProSoft Engineering, especially as we complete our Beta prototype. Their experienced staff will be invaluable in assisting Imaging3 as it transitions from prototype to full production of the Dominion device," said Dean Janes, CEO of Imaging3.
SyProSoft has tremendous expertise in diagnostic imaging software engineering which gives Imaging3 an efficient and high value means to increase speed and competency in development. "This is especially important as we add features and functionality to our developing product. SyProSoft's familiarity with common software functionality and interfaces, such as CT and Dicom, is extremely valuable for fast and effective implementation," concluded Janes.
About Imaging3
Imaging3, Inc., founded in 1993, is a leading provider of advanced technology medical imaging devices. The Company has developed a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time. Because these 3D images are instantly constructed in real-time, they can be used for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body. Visit the company's website at www.imaging3.com
Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company.